- $411.70m
- $838.80m
- $361.06m
- 49
- 97
- 58
- 76
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 196 | 113 | 196 | 347 | 361 |
Cost of Revenue | |||||
Gross Profit | 138 | 76.2 | 181 | 324 | 336 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 136 | 382 | 101 | 156 | 215 |
Operating Profit | 60.1 | -269 | 95.8 | 192 | 146 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 43.3 | -259 | 3.41 | 147 | 105 |
Provision for Income Taxes | |||||
Net Income After Taxes | 29.5 | -253 | 3.32 | 139 | 105 |
Net Income Before Extraordinary Items | |||||
Net Income | 29.5 | -253 | 3.32 | 139 | 105 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 29.5 | -253 | 3.32 | 139 | 105 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.484 | -1 | 0.027 | 0.978 | 0.537 |